Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vomiting 1Rectal Neoplasms 1Prostatic Neoplasms 1Postoperative Nausea and Vomiting 1Neoplastic Cells, Circulating 1Nausea 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Dexamethasone 36Aprepitant 31Palonosetron 27Ondansetron 23Granisetron 14fosaprepitant 13Calcium Dobesilate 12Olanzapine 11Therapeutics 7ramosetron 6dexamethasone acetate 5Tropisetron 5Doxorubicin 5Cyclophosphamide 5Surveys and Questionnaires 4Metoclopramide 4netupitant, palosentron drug combination 3netupitant 3dolasetron 3dexamethasone 21-phosphate 3Yoga 3Vincristine 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3Dronabinol 3Diphenhydramine 3Acupressure 3ginger extract 2Thalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Vomiting × Antiemetics × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡